Dual Programmed Cell Death Pathways Induced by p53 Transactivation Overcome Resistance to Oncolytic Adenovirus in Human Osteosarcoma CellsJoe Hasei, Toshiyoshi Fujiwara, Toshifumi Ozaki et al.|Molecular Cancer Therapeutics|2013Cited by 62
Preclinical Evaluation of Telomerase-Specific Oncolytic Virotherapy for Human Bone and Soft Tissue SarcomasTsuyoshi Sasaki, Toshiyoshi Fujiwara, Aki Yoshida et al.|Clinical Cancer Research|2011Cited by 52
Ablation of MCL1 expression by virally induced microRNA-29 reverses chemoresistance in human osteosarcomasShuhei Osaki, Toshiyoshi Fujiwara, Toshifumi Ozaki et al.|Scientific Reports|2016Cited by 45
Telomerase-specific oncolytic immunotherapy for promoting efficacy of PD-1 blockade in osteosarcomaYusuke Mochizuki, Toshiyoshi Fujiwara, Toshifumi Ozaki et al.|Cancer Immunology Immunotherapy|2020Cited by 29